414 related articles for article (PubMed ID: 28665164)
1. Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.
Zhang M; Wang X; Han MK; Collins JF; Merlin D
Nanomedicine (Lond); 2017 Aug; 12(16):1927-1943. PubMed ID: 28665164
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.
Xiao B; Laroui H; Viennois E; Ayyadurai S; Charania MA; Zhang Y; Zhang Z; Baker MT; Zhang B; Gewirtz AT; Merlin D
Gastroenterology; 2014 May; 146(5):1289-300.e1-19. PubMed ID: 24503126
[TBL] [Abstract][Full Text] [Related]
3. Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy.
Zhang M; Xiao B; Wang H; Han MK; Zhang Z; Viennois E; Xu C; Merlin D
Mol Ther; 2016 Oct; 24(10):1783-1796. PubMed ID: 27491931
[TBL] [Abstract][Full Text] [Related]
4. Oral Administration of Ginger-Derived Lipid Nanoparticles and Dmt1 siRNA Potentiates the Effect of Dietary Iron Restriction and Mitigates Pre-Existing Iron Overload in
Wang X; Zhang M; Woloshun RR; Yu Y; Lee JK; Flores SRL; Merlin D; Collins JF
Nutrients; 2021 May; 13(5):. PubMed ID: 34063414
[TBL] [Abstract][Full Text] [Related]
5. Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer.
Zhang M; Viennois E; Prasad M; Zhang Y; Wang L; Zhang Z; Han MK; Xiao B; Xu C; Srinivasan S; Merlin D
Biomaterials; 2016 Sep; 101():321-40. PubMed ID: 27318094
[TBL] [Abstract][Full Text] [Related]
6. Preparation and Characterization of Ginger Lipid-derived Nanoparticles for Colon-targeted siRNA Delivery.
Sung J; Yang C; Collins JF; Merlin D
Bio Protoc; 2020 Jul; 10(14):. PubMed ID: 32782915
[TBL] [Abstract][Full Text] [Related]
7. Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.
Laroui H; Geem D; Xiao B; Viennois E; Rakhya P; Denning T; Merlin D
Mol Ther; 2014 Jan; 22(1):69-80. PubMed ID: 24025751
[TBL] [Abstract][Full Text] [Related]
8. Oral Gavage of Ginger Nanoparticle-Derived Lipid Vectors Carrying Dmt1 siRNA Blunts Iron Loading in Murine Hereditary Hemochromatosis.
Wang X; Zhang M; Flores SRL; Woloshun RR; Yang C; Yin L; Xiang P; Xu X; Garrick MD; Vidyasagar S; Merlin D; Collins JF
Mol Ther; 2019 Mar; 27(3):493-506. PubMed ID: 30713087
[TBL] [Abstract][Full Text] [Related]
9. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
[TBL] [Abstract][Full Text] [Related]
10. Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.
Wilson DS; Dalmasso G; Wang L; Sitaraman SV; Merlin D; Murthy N
Nat Mater; 2010 Nov; 9(11):923-8. PubMed ID: 20935658
[TBL] [Abstract][Full Text] [Related]
11. Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer.
Xiao B; Viennois E; Chen Q; Wang L; Han MK; Zhang Y; Zhang Z; Kang Y; Wan Y; Merlin D
ACS Nano; 2018 Jun; 12(6):5253-5265. PubMed ID: 29860836
[TBL] [Abstract][Full Text] [Related]
12. Oral delivery of IL-22 mRNA-loaded lipid nanoparticles targeting the injured intestinal mucosa: A novel therapeutic solution to treat ulcerative colitis.
Sung J; Alghoul Z; Long D; Yang C; Merlin D
Biomaterials; 2022 Sep; 288():121707. PubMed ID: 35953326
[TBL] [Abstract][Full Text] [Related]
13. Arrowtail RNA for Ligand Display on Ginger Exosome-like Nanovesicles to Systemic Deliver siRNA for Cancer Suppression.
Li Z; Wang H; Yin H; Bennett C; Zhang HG; Guo P
Sci Rep; 2018 Oct; 8(1):14644. PubMed ID: 30279553
[TBL] [Abstract][Full Text] [Related]
14. CD98 siRNA-loaded nanoparticles decrease hepatic steatosis in mice.
Canup BS; Song H; Le Ngo V; Meng X; Denning TL; Garg P; Laroui H
Dig Liver Dis; 2017 Feb; 49(2):188-196. PubMed ID: 27939923
[TBL] [Abstract][Full Text] [Related]
15. Biomimetic MOF Nanoparticles Delivery of C-Dot Nanozyme and CRISPR/Cas9 System for Site-Specific Treatment of Ulcerative Colitis.
Ma Y; Gao W; Zhang Y; Yang M; Yan X; Zhang Y; Li G; Liu C; Xu C; Zhang M
ACS Appl Mater Interfaces; 2022 Feb; 14(5):6358-6369. PubMed ID: 35099925
[TBL] [Abstract][Full Text] [Related]
16. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
17. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
[TBL] [Abstract][Full Text] [Related]
18. Development of a carrier system containing hyaluronic acid and protamine for siRNA delivery in the treatment of melanoma.
Yang J; Zhao R; Feng Q; Zhuo X; Wang R
Invest New Drugs; 2021 Feb; 39(1):66-76. PubMed ID: 32794135
[TBL] [Abstract][Full Text] [Related]
19. Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis.
Huang Y; Guo J; Gui S
Eur J Pharm Sci; 2018 Dec; 125():232-243. PubMed ID: 30315858
[TBL] [Abstract][Full Text] [Related]
20. Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophages.
Xiao B; Ma P; Viennois E; Merlin D
Colloids Surf B Biointerfaces; 2016 Jul; 143():186-193. PubMed ID: 27011348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
